UiPath (NYSE:PATH – Get Free Report) had its target price reduced by research analysts at UBS Group from $19.00 to $15.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price objective points to a potential upside of 13.11% from the stock’s previous close.
A number of other equities analysts have also recently commented on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $22.00 price target on shares of UiPath in a research note on Wednesday. Canaccord Genuity Group restated a “hold” rating and issued a $17.00 price objective (up from $15.00) on shares of UiPath in a research report on Friday, September 4th. HC Wainwright reaffirmed a “buy” rating on shares of UiPath in a research note on Friday, September 4th. BMO Capital Markets increased their target price on shares of UiPath from $13.00 to $18.00 and gave the stock a “market perform” rating in a report on Friday, September 4th. Finally, Citigroup began coverage on UiPath in a research note on Tuesday, September 8th. They issued a “buy” rating and a $23.00 target price on the stock. Three investment analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, UiPath presently has a consensus rating of “Hold” and an average target price of $16.56.
Get Our Latest Stock Analysis on UiPath
UiPath Stock Down 2.4%
UiPath (NYSE:PATH – Get Free Report) last released its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, hitting the consensus estimate of $0.15. UiPath had a return on equity of 9.70% and a net margin of 21.03%.The firm had revenue of $410.26 million for the quarter, compared to the consensus estimate of $397.77 million. During the same quarter in the previous year, the business earned $0.15 earnings per share. The company’s quarterly revenue was up 13.3% on a year-over-year basis. Equities analysts expect that UiPath will post 0.47 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, COO Ashim Gupta sold 117,339 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $13.85, for a total transaction of $1,625,145.15. Following the completion of the transaction, the chief operating officer directly owned 2,037,377 shares in the company, valued at $28,217,671.45. This trade represents a 5.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Raghavendra Malpani sold 40,464 shares of UiPath stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $14.00, for a total value of $566,496.00. Following the completion of the transaction, the insider directly owned 1,582,213 shares of the company’s stock, valued at approximately $22,150,982. This represents a 2.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,560,150 shares of company stock worth $24,727,357 in the last three months. 22.44% of the stock is owned by corporate insiders.
Institutional Trading of UiPath
A number of institutional investors and hedge funds have recently modified their holdings of the business. Pasadena Private Wealth LLC boosted its position in shares of UiPath by 9.0% during the 1st quarter. Pasadena Private Wealth LLC now owns 12,750 shares of the company’s stock worth $142,000 after purchasing an additional 1,050 shares in the last quarter. Allworth Financial LP boosted its position in UiPath by 5.2% during the second quarter. Allworth Financial LP now owns 23,537 shares of the company’s stock worth $256,000 after purchasing an additional 1,160 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of UiPath by 36.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company’s stock valued at $81,000 after buying an additional 1,329 shares in the last quarter. Corient Private Wealth LLC grew its stake in UiPath by 5.6% in the 4th quarter. Corient Private Wealth LLC now owns 27,283 shares of the company’s stock valued at $447,000 after acquiring an additional 1,455 shares during the last quarter. Finally, Wedbush Securities Inc. lifted its holdings in shares of UiPath by 14.0% in the second quarter. Wedbush Securities Inc. now owns 11,920 shares of the company’s stock valued at $130,000 after purchasing an additional 1,465 shares in the last quarter. Institutional investors own 62.50% of the company’s stock.
Key UiPath News
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: Needham reaffirmed its “Buy” rating and $22 price target, implying substantial upside from recent trading levels. The bullish view provides support for PATH and reflects confidence in UiPath’s long-term growth prospects. Benzinga analyst rating article
- Positive Sentiment: Some valuation analysis suggests UiPath may be undervalued based on its cash-flow potential. The company also trades at a lower earnings multiple than the S&P 500 median despite its software growth profile. UiPath stock valuation article
- Positive Sentiment: Technical commentary points to a potential breakout after recent consolidation below $14, while UiPath’s agentic automation and enterprise RPA positioning continue to attract investor attention. UiPath breakout signal article
- Neutral Sentiment: UiPath’s Analyst/Investor Day slideshow offers investors additional information on its strategy and outlook, but the available report does not identify a specific new financial catalyst. UiPath Analyst Investor Day slideshow
- Negative Sentiment: Investors remain concerned that artificial intelligence could eventually pressure UiPath’s traditional automation business, even though current operating results have not yet shown a material impact. The stock has pulled back sharply from its recent high, increasing focus on this risk. UiPath AI risk and valuation article
- Negative Sentiment: CTO Raghavendra Malpani sold 40,464 shares for approximately $566,000, reducing his direct ownership by 2.49%. While the sale is modest relative to his remaining stake, insider selling can weigh on sentiment. UiPath insider sale report
About UiPath
UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.
The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.
Featured Stories
- Five stocks we like better than UiPath
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
- Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
- 3 Tech Stocks Positioned for More Upside if the Sector’s Breakout Holds
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
